Sign Out
CRYSVITA 10 mg solution for injection: Each vial contains 10 mg of burosumab in 1 ml solution.
Burosumab is a recombinant human monoclonal IgG1 antibody for FGF23 and is produced by recombinant DNA technology using Chinese hamster ovary (CHO) mammalian cell culture.
Excipient with known effect: Each vial contains 45.91 mg sorbitol.
Excipients/Inactive Ingredients: L-histidine, D-sorbitol E420, Polysorbate 80, L-methionine, 10% hydrochloric acid (for pH adjustment), Water for injections.
